Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

818 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Adverse effects of antiretroviral therapy.
Carr A, Cooper DA. Carr A, et al. Among authors: cooper da. Lancet. 2000 Oct 21;356(9239):1423-30. doi: 10.1016/S0140-6736(00)02854-3. Lancet. 2000. PMID: 11052597 Review.
Randomized, placebo-controlled, phase I/IIa evaluation of the safety and immunogenicity of fowlpox virus expressing HIV gag-pol and interferon-gamma in HIV-1 infected subjects.
Emery S, Workman C, Puls RL, Bloch M, Baker D, Bodsworth N, Anderson J, Crowe SM, French MA, Hoy J, Aichelburg A, Ward LD, Boyle DB, Law MG, Kelleher AD, Cooper DA. Emery S, et al. Among authors: cooper da. Hum Vaccin. 2005 Nov-Dec;1(6):232-8. doi: 10.4161/hv.1.6.2342. Epub 2005 Nov 12. Hum Vaccin. 2005. PMID: 17012863 Clinical Trial.
Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT).
Pett SL, Carey C, Lin E, Wentworth D, Lazovski J, Miró JM, Gordin F, Angus B, Rodriguez-Barradas M, Rubio R, Tambussi G, Cooper DA, Emery S; INSIGHT-ESPRIT Study Group. Pett SL, et al. Among authors: cooper da. HIV Med. 2011 Apr;12(4):219-27. doi: 10.1111/j.1468-1293.2010.00875.x. Epub 2010 Aug 31. HIV Med. 2011. PMID: 20812949 Free PMC article. Clinical Trial.
No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial.
Calmy A, Bloch M, Wand H, Delhumeau C, Finlayson R, Rafferty M, Norris R, Hirschel B, Cooper DA, Carr A; URISTAT study group. Calmy A, et al. Among authors: cooper da. HIV Med. 2010 Sep;11(8):493-501. doi: 10.1111/j.1468-1293.2009.00817.x. Epub 2010 Mar 8. HIV Med. 2010. PMID: 20236365 Clinical Trial.
Poly-l-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-up.
Carey D, Baker D, Petoumenos K, Chuah J, Rogers GD, Watson J, Cooper DA, Emery S, Carr A; FLASH Investigators. Carey D, et al. Among authors: cooper da. HIV Med. 2009 Mar;10(3):163-72. doi: 10.1111/j.1468-1293.2008.00667.x. HIV Med. 2009. PMID: 19245538 Clinical Trial.
818 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page